The Road to Rejuvenation
Fortified stem cells. Enhanced memory. A longevity hormone. UCSF researchers are finding out whether we can cancel – or at least delay – old age.
University of California San Francisco
Give to UCSF
Eczema and Asthma Share a Link. Can it Lead to New Treatments?
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
The Surgeon Set on Curing Genetic Diseases Before Birth
Tippi MacKenzie is leading grounbreaking clinical trials of therapies aimed at stopping fetuses from developing devastating disorders.
Can Lab-Grown Beta Cells Revolutionize Diabetes Care?
Sneddon is trying to coax stem cells into reliably developing functional beta cells that can then be transplanted into patients with diabetes so that they can produce their own insulin.
Can a Leading Laboratory Unlock the Cause of Gastrointestinal Disease?
Faranak Fattahi’s lab is a national leader in growing stem cells to model peripheral nerves, focusing on gastrointestinal diseases.
Why Stem Cell Therapy Might Not Work for Older Patients
Leanne Jones, PhD, is at the forefront of studying how stem cells are influenced by their surrounding environment and directed to differentiate into one type of cell or another – research that’s critical for stem cell therapies to be successful.
What We Were Taught About RNA in High School is Only Half the Picture
Vissers’ work on RNA tags helped found the field of epitranscriptomics, the study of how chemical marks on RNA, rather than their sequence alone, dictate the function of the molecules.
3 UCSF Faculty Elected to the National Academy of Medicine for 2022
Three UCSF faculty members are among the 100 new national members elected this year to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine.
Renowned Hematology-Oncology Specialist to Lead UCSF Health’s Hematology-Oncology Program
UCSF’s Division of Hematology-Oncology is welcoming Krishna Komanduri, MD, as division chief of Hematology-Oncology at UCSF Health. Komanduri is an international leader in the fields of hematology-oncology, transplantation, and cellular immunotherapy. He will start at UCSF on July 1.
Engineered Cells Successfully Treat Cardiovascular and Pulmonary Disease
Scientists at UCSF have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases in mice.
Living Therapeutics Initiative Will Accelerate Development and Delivery of Revolutionary Treatments
UCSF is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease – and bring them quickly to patients.
Cellular Transplant Therapy Pioneered by UCSF Reverses Sea Lion’s Epilepsy
Cronutt was one sick sea lion before undergoing a groundbreaking surgery last fall. Today he's seizure-free and doing well.
UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease
Scientists at UC San Francisco, UC Berkeley and UCLA have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patient’s own blood-forming stem cells.
Science of Aging is Focus of New Bakar Research Institute
The new Institute will bring together scientists and clinicians from all UCSF sites to address the most critical questions related to the science of aging.
‘Invisible’ Stem Cells Evade Natural Killer Cells Using Immune ‘Off-Switch’
UCSF scientists have discovered a new way to control the immune system’s “natural killer” cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection.
